FRONTRUNNER XP CTO Catheter
FRONTRUNNER XP CTO Catheter
Clinical Indication
Chronic total occlusions (CTOs) represent some of the most technically demanding lesions in peripheral and coronary intervention — fibrotic, calcified, and organized thrombus that cannot be traversed by conventional guidewires alone. For cath lab teams managing these cases, the FRONTRUNNER XP CTO Catheter is the definitive blunt microdissection solution for CTO crossing.
Device Mechanism
The FRONTRUNNER XP employs a spring-loaded actuating jaw at its distal tip: operator-triggered micro-expansions of 0.018” create repetitive blunt dissection planes through the fibrous CTO cap and body without sharp perforation risk, advancing through occlusive tissue by separating rather than cutting.
The 3.2Fr catheter shaft is engineered for pushability and torque transmission through tortuous access paths, and the system is designed for use in conjunction with 0.014” or 0.018” guidewires for subsequent true lumen recanalization. The FRONTRUNNER XP is FDA 510(k)-cleared for peripheral CTO crossing and carries CE Mark for use across EU member states.
Product Gallery
Performance Data
| Field | Specification |
|---|---|
| Crossing Mechanism | Blunt microdissection via spring-loaded actuating jaw; separates rather than cuts occlusive tissue |
| Catheter Size | 3.2Fr shaft |
| Compatible Guidewire | 0.014” and 0.018” guidewires |
| Jaw Actuation | Operator-triggered micro-expansions of 0.018”; spring-loaded distal jaw |
| Regulatory Status | FDA 510(k)-cleared (peripheral CTO crossing); CE Mark (EU member states) |
| Indicated Vessel Territory | Peripheral vasculature (femoropopliteal and related segments) |
| Shaft Design | High-pushability, torque-transmitting shaft optimized for tortuous access paths |